Nanobiotix (NBTX) Non-Current Debt (2019 - 2025)

Historic Non-Current Debt for Nanobiotix (NBTX) over the last 7 years, with Q2 2025 value amounting to $52.6 million.

  • Nanobiotix's Non-Current Debt rose 1067.57% to $52.6 million in Q2 2025 from the same period last year, while for Jun 2025 it was $52.6 million, marking a year-over-year increase of 1067.57%. This contributed to the annual value of $49.8 million for FY2024, which is 101.31% up from last year.
  • According to the latest figures from Q2 2025, Nanobiotix's Non-Current Debt is $52.6 million, which was up 1067.57% from $49.1 million recorded in Q4 2024.
  • In the past 5 years, Nanobiotix's Non-Current Debt ranged from a high of $53.0 million in Q2 2021 and a low of $28.1 million during Q4 2022
  • In the last 5 years, Nanobiotix's Non-Current Debt had a median value of $48.5 million in 2023 and averaged $45.7 million.
  • As far as peak fluctuations go, Nanobiotix's Non-Current Debt crashed by 2748.04% in 2022, and later skyrocketed by 7465.12% in 2023.
  • Nanobiotix's Non-Current Debt (Quarter) stood at $53.0 million in 2021, then plummeted by 47.04% to $28.1 million in 2022, then skyrocketed by 74.65% to $49.0 million in 2023, then rose by 0.27% to $49.1 million in 2024, then increased by 7.14% to $52.6 million in 2025.
  • Its Non-Current Debt was $52.6 million in Q2 2025, compared to $49.1 million in Q4 2024 and $47.6 million in Q2 2024.